Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription

Endocrinology

Volumn 150, Issue 8, 2009, Pages 3645-3654

  Chen, Yili ^a   Lin, Grace ^a   Huo, Jeffrey S ^a   Barney, Deborah ^b   Wang, Zhenni ^b   Livshiz, Tamara ^b   States, David J ^a,b   Qin, Zhaohui S ^a   Schwartz, Jessica ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 6; PROTEIN SH2; PROTEIN SUBUNIT; SOMATOMEDIN C; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2;

ARTICLE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANIMALS; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; COMPUTATIONAL BIOLOGY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GROWTH HORMONE; IMMUNOBLOTTING; MICE; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 67651162130     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0212     Document Type: Article

References (74)

1. Lanning NJ, Carter-Su C 2006 Recent advances in growth hormone signaling. Rev Endocr Metab Disord 7:225-235
2. Carter-Su C, Schwartz J, Smit LS 1996 Molecular mechanism of growth hormone action. Annu Rev Physiol 58:187-207
3. Mathews LS, Norstedt G, Palmiter RD 1986 Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Nat Acad Sci USA 83:9343-9347
4. Woelfle J, Billiard J, Rotwein P 2003 Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem 278:22696-22702
5. Enberg B, Hulthén A, Möller C, Norstedt G, Francis SM 1994 Growth hormone (GH) regulation of a rat serine protease inhibitor fusion gene in cells transfected with GH receptor cDNA. J Mol Endocrinol 12:39-46
6. Bergad PL, Schwarzenberg SJ, Humbert JT, Morrison M, Amarasinghe S, Towle HC, Berry SA 2000 Inhibition of growth hormone action in models of inflammation. Am J Physiol Cell Physiol 279:C1906-C1917
7. Doglio A, Dani C, Grimaldi P, Ailhaud G 1989 Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover. Proc Natl Acad Sci USA 86:1148-1152
8. Sundseth SS, Alberta JA, Waxman DJ 1992 Sex-specific, growth hormone-regulated transcription of the cytochrome P450 2C11 and 2C12 genes. J Biol Chem 267:3907-3914
9. Waxman DJ, O'Connor C 2006 Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 20:2613-2629
10. Gurland G, Ashcom G, Cochran BH, Schwartz J 1990 Rapid events in growth hormone action. Induction of c-fos and c-jun transcription in 3T3-F442A preadipocytes. Endocrinology 127:3187-3195
11. Houssay BA, Biasotti A 1930 Hypophysectomie et diabete pancreatique chez le crapaud. C R Soc Biol (Paris) 104:407-412
12. Dominici FP, Turyn D 2002 Growth hormone-induced alterations in the insulin-signaling system. Exp Biol Med (Maywood) 227:149-157
13. Davidson MB 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131
14. Barbour LA, Mizanoor Rahman S, Gurevich I, Leitner JW, Fischer SJ, Roper MD, Knotts TA, Vo Y, McCurdy CE, Yakar S, Leroith D, Kahn CR, Cantley LC, Friedman JE, Draznin B 2005 Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem 280:37489-37494
15. del Rincon JP, Iida K, Gaylinn BD, McCurdy CE, Leitner JW, Barbour LA, Kopchick JJ, Friedman JE, Draznin B, Thorner MO 2007 Growth hormone regulation of p85′ expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 56:1638-1646
16. Huo JS, McEachin RC, Cui TX, Duggal NK, Hai T, States DJ, Schwartz J 2006 Profiles of growth hormone (GH)-regulated genes reveal time-dependent responses and identify a mechanism for regulation of activating transcription factor 3 by GH. J Biol Chem 281:4132-4141
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550
18. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M 1999 KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27:29-34
19. Kanehisa M, Goto S, Kawashima S, Nakaya A 2002 The KEGG databases at Genome Net. Nucleic Acids Res 30:42-46
20. Kanehisa M, Goto S 2000 KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27-30
21. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264
22. Qin ZS 2006 Clustering microarray gene expression data using weighted Chinese restaurant process. Bioinformatics 22:1988-1997
23. Sugimoto N, Oida T, Hirota K, Nakamura K, Nomura T, Uchiyama T, Sakaguchi S 2006 Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int Immunol 18:1197-1209
24. Pritchard CC, Hsu L, Delrow J, Nelson PS 2001 Project normal: defining normal variance in mouse gene expression. Proc Natl Acad Sci USA 98:13266-13271
25. Salazard B, Bellon L, Jean S, Maraninchi M, El-Yazidi C, Orsière T, Margotat A, Botta A, Bergé-Lefranc JL 2004 Low-level arsenite activates the transcription of genes involved in adipose differentiation. Cell Biol Toxicol 20:375-385
26. Waters KM, Safe S, Gaido KW 2001 Differential gene expression in response to methoxychlor and estradiol through ERα, ERβ, and AR in reproductive tissues of female mice. Toxicol Sci 63:47-56
27. Liao J, Piwien-Pilipuk G, Ross SE, Hodge CL, Sealy L, MacDougald OA, Schwartz J 1999 CCAAT/enhancer-binding protein β (C/EBPβ) and C/EBPδ contribute to growth hormone-regulated transcription of c-fos. J Biol Chem 274:31597-31604
28. Ceseña TI, Cardinaux JR, Kwok R, Schwartz J 2007 CCAAT/enhancer-binding protein (C/EBP) β is acetylated at multiple lysines: acetylation of C/EBPβ at lysine 39 modulates its ability to activate transcription. J Biol Chem 282:956-967
29. Vidal OM, Merino R, Rico-Bautista E, Fernandez-Perez L, Chia DJ, Woelfle J, Ono M, Lenhard B, Norstedt G, Rotwein P, Flores-Morales A 2007 In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver. Mol Endocrinol 21:293-311
30. Baron BW, Zeleznik-Le N, Baron MJ, Theisler C, Huo D, Krasowski MD, Thirman MJ, Baron RM, Baron JM 2007 Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas. Proc Nat Acad Sci USA 104:7449-7454
31. Wang X, Möller C, Norstedt G, Carter-Su C 1993 Growth hormone-promoted tyrosyl phosphorylation of a 121-kDa growth hormone receptor-associated protein. J Biol Chem 268:3573-3579
32. Piwien-Pilipuk G, MacDougald O, Schwartz J 2002 Dual regulation of phosphorylation and dephosphorylation of C/EBPβ modulate its transcriptional activation and DNA binding in response to growth hormone. J Biol Chem 277:44557-44565
33. Cui TX, Piwien-Pilipuk G, Huo JS, Kaplani J, Kwok R, Schwartz J 2005 Endogenous CCAAT/enhancer binding protein β and p300 are both regulated by growth hormone to mediate transcriptional activation. Mol Endocrinol 19:2175-2186
34. Kato H, Nomura K, Osabe D, Shinohara S, Mizumori O, Katashima R, Iwasaki S, Nishimura K, Yoshino M, Kobori M, Ichiishi E, Nakamura N, Yoshikawa T, Tanahashi T, Keshavarz P, Kunika K, Moritani M, Kudo E, Tsugawa K, Takata Y, Hamada D, Yasui N, Miyamoto T, Shiota H, Inoue H, Itakura M 2006 Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the Japanese. Genomics 87:446-458
35. Isaksson OG, Edén S, Jansson JO 1985 Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol 47:483-499
36. Eisen MB, Spellman PT, Brown PO, Botstein D 1998 Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868
37. Woelfle J, Rotwein P 2004 In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am J Physiol Endocrinol Metab 286:E393-E401
38. Tollet-Egnell P, Flores-Morales A, Stavréus-Evers A, Sahlin L, Norstedt G 1999 Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology 140:3693-3704
39. Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, Fontaine M, Yen MH, Kim SK 2007 Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318:806-809
40. Walker SR, Nelson EA, Frank DA 2007 STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene 26:224-233
41. Scheeren FA, Naspetti M, Diehl S, Schotte R, Nagasawa M, Wijnands E, Gimeno R, Vyth-Dreese FA, Blom B, Spits H 2005 STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat Immunol 6:303-313
42. Ceseña TI, Cui TX, Piwien-Pilipuk G, Kaplani J, Calinescu AA, Huo JS, Iñiguez-Lluhí JA, Kwok R, Schwartz J 2007 Multiple mechanisms of growth hormone-regulated gene transcription. Mol Genet Metab 90:126-133
43. Herrington J, Smit LS, Schwartz J, Carter-Su C 2000 The role of STAT proteins in growth hormone signaling. Oncogene 19:2585-2597
44. Yarwood SJ, Kilgour E, Anderson NG 1998 Cyclic AMP potentiates growth hormone-dependent differentiation of 3T3-F442A preadipocytes: possible involvement of the transcription factor CREB. Mol Cell Endocrinol 138:41-50
45. Cui TX, Kwok R, Schwartz J 2008 Cooperative regulation of endogenous cAMP-response element binding protein and CCAAT/enhancer-binding protein β in GH-stimulated c-fos expression. J Endocrinol 196:89-100
46. Turnley AM 2005 Role of SOCS2 in growth hormone actions. Trends Endocrinol Metab 16:53-58
47. Krebs DL, Hilton DJ 2001 SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378-387
48. Jardin F, Ruminy P, Bastard C, Tilly H 2007 The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis. Pathol Biol (Paris) 55:73-83
49. Ci W, Polo JM, Melnick A 2008 B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma. Curr Opin Hematol 15:381-390
50. Wong CW, Privalsky ML 1998 Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARα, and BCL-6. J Biol Chem 273:27695-27702
51. Huynh KD, Bardwell VJ 1998 The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 17:2473-2484
52. Huynh KD, Fischle W, Verdin E, Bardwell VJ 2000 BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 14:1810-1823
53. Dhordain P, Albagli O, Lin RJ, Ansieau S, Quief S, Leutz A, Kerckaert JP, Evans RM, Leprince D 1997 Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Nat Acad Sci USA 94:10762-10767
54. Chevallier N, Corcoran CM, Lennon C, Hyjek E, Chadburn A, Bardwell VJ, Licht JD, Melnick A 2004 ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. Blood 103:1454-1463
55. Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, Boss JM, Wade PA 2004 MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119:75-86
56. Mendez LM, Polo JM, Yu JJ, Krupski M, Ding BB, Melnick A, Ye BH 2008 CtBP is an essential corepressor for BCL6 autoregulation. Mol Cell Biol 28:2175-2186
57. Ono M, Chia DJ, Merino-Martinez R, Flores-Morales A, Unterman TG, Rotwein P 2007 Signal transducer and activator of transcription (Stat) 5b-mediated inhibition of insulin-like growth factor binding protein-1 gene transcription: a mechanism for repression of gene expression by growth hormone. Mol Endocrinol 21:1443-1457
58. Wauthier V, Waxman DJ 2008 Sex-specific early growth hormone response genes in rat liver. Mol Endocrinol 22:1962-1974
59. Holloway MG, Laz EV, Waxman DJ 2006 Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4α. Mol Endocrinol 20:647-660
60. Harris MB, Chang CC, Berton MT, Danial NN, Zhang J, Kuehner D, Ye BH, Kvatyuk M, Pandolfi PP, Cattoretti G, Dalla-Favera R, Rothman PB 1999 Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol Cell Biol 19:7264-7275
61. Nelson EA, Walker SR, Alvarez JV, Frank DA 2004 Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J Biol Chem 279:54724-54730
62. Bereshchenko OR, Gu W, Dalla-Favera R 2002 Acetylation inactivates the transcriptional repressor BCL6. Nat Genet 32:606-613
63. Niu H, Ye BH, Dalla-Favera R 1998 Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev 12:1953-1961
64. Diehl SA, Schmidlin H, Nagasawa M, van Haren SD, Kwakkenbos MJ, Yasuda E, Beaumont T, Scheeren FA, Spits H 2008 STAT3-mediated upregulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol 180:4805-4815
65. Tran TH, Utama FE, Lin J, Neilson LM, Sjolund AB, Rui H, Prolactin inhibits expression of B-cell lymphoma 6 (BCL6) in breast cancer through a Stat5 dependent mechanism. Program of the 90th Annual Meeting of The Endocrine Society, San Francisco, CA, 2008, p 634 (Abstract P3-135)
66. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R 1997 The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16:161-170
67. Yoshida T, Fukuda T, Hatano M, Koseki H, Okabe S, Ishibashi K, Kojima S, Arima M, Komuro I, Ishii G, Miki T, Hirosawa S, Miyasaka N, Taniguchi M, Ochiai T, Isono K, Tokuhisa T 1999 The role of Bcl6 in mature cardiac myocytes. Cardiovasc Res 42:670-679
68. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM 1997 Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-592
69. Parikh H, Carlsson E, Chutkow WA, Johansson LE, Storgaard H, Poulsen P, Saxena R, Ladd C, Schulze PC, Mazzini MJ, Jensen CB, Krook A, Björnholm M, Tornqvist H, Zierath JR, Ridderstråle M, Altshuler D, Lee RT, Vaag A, Groop LC, Mootha VK 2007 TXNIP regulates peripheral glucose metabolism in humans. PLoS Med 4:e158
70. Hogan JC, Stephens JM 2005 The regulation of fatty acid synthase by STAT5A. Diabetes 54:1968-1975
71. White UA, Coulter AA, Miles TK, Stephens JM 2007 The STAT5A-mediated induction of pyruvate dehydrogenase kinase 4 expression by prolactin or growth hormone in adipocytes. Diabetes 56:1623-1629
72. Shang CA, Waters MJ 2003 Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. Mol Endocrinol 17:2494-2508
73. Kawai M, Namba N, Mushiake S, Etani Y, Nishimura R, Makishima M, Ozono K 2007 Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARγ pathway. J Mol Endocrinol 38:19-34
74. Foster CM, Hale PM, Jing HW, Schwartz J 1988 Effects of human growth hormone on insulin-stimulated glucose metabolism in 3T3-F442A adipocytes. Endocrinology 123:1082-1088